Javascript must be enabled to continue!
Homeodomain Expression in AML and T-ALL Cell Lines.
View through CrossRef
Abstract
HOX genes are frequent targets of chromosomal translocations and retroviral integrations in human and murine acute leukemia, often involving genes at the 5′-end of the HOX clusters. We previously reported that HOX expression patterns in AML were related to prognostic cytogenetic subsets. We also identified a distinct subset of patients with intermediate cytogenetics based on high levels of HOX and FLT3 expression, frequent FLT3 mutations and a low incidence of C/EBPa mutations. Certain cases of T-ALL also have rearrangements of homeodomain genes and some T-ALLs express limited myeloid markers. To further explore the spectrum of homeodomain gene expression, we developed qRT-PCR assays for nearly all clustered HOXA-D genes, selected homeodomain genes on chromosomes often altered in AML, and selected polycomb (Pc) genes, FLT3 and MLL. Altogether, 52 genes were analyzed in 32 AML and T-ALL cell lines. FLT3 expression was confined to a subset of AMLs. HOX11, HOX11L2 and NKX2.5 were expressed only in cases involving rearrangements of these genes. The Pc and MLL genes were uniformly expressed. Among HOX clusters, the frequency of gene expression was HOXA>B>C>D. Genes more highly expressed in the HOXC and D clusters were those at the 5′-ends (e.g., D13, C10). Marked or selective overexpression of individual genes suggests their possible involvement in the disease process, immortalization or differentiation. Examples include EN1 (SUPT1), D13 (MEGA1, B9 (PEER). A hierarchical cluster analysis based on homeodomain genes successfully identified subsets of related cell lines. Thus, the analysis of quantitative HOX expression may provide an important new tool to better understand the biology of acute leukemia.
American Society of Hematology
Title: Homeodomain Expression in AML and T-ALL Cell Lines.
Description:
Abstract
HOX genes are frequent targets of chromosomal translocations and retroviral integrations in human and murine acute leukemia, often involving genes at the 5′-end of the HOX clusters.
We previously reported that HOX expression patterns in AML were related to prognostic cytogenetic subsets.
We also identified a distinct subset of patients with intermediate cytogenetics based on high levels of HOX and FLT3 expression, frequent FLT3 mutations and a low incidence of C/EBPa mutations.
Certain cases of T-ALL also have rearrangements of homeodomain genes and some T-ALLs express limited myeloid markers.
To further explore the spectrum of homeodomain gene expression, we developed qRT-PCR assays for nearly all clustered HOXA-D genes, selected homeodomain genes on chromosomes often altered in AML, and selected polycomb (Pc) genes, FLT3 and MLL.
Altogether, 52 genes were analyzed in 32 AML and T-ALL cell lines.
FLT3 expression was confined to a subset of AMLs.
HOX11, HOX11L2 and NKX2.
5 were expressed only in cases involving rearrangements of these genes.
The Pc and MLL genes were uniformly expressed.
Among HOX clusters, the frequency of gene expression was HOXA>B>C>D.
Genes more highly expressed in the HOXC and D clusters were those at the 5′-ends (e.
g.
, D13, C10).
Marked or selective overexpression of individual genes suggests their possible involvement in the disease process, immortalization or differentiation.
Examples include EN1 (SUPT1), D13 (MEGA1, B9 (PEER).
A hierarchical cluster analysis based on homeodomain genes successfully identified subsets of related cell lines.
Thus, the analysis of quantitative HOX expression may provide an important new tool to better understand the biology of acute leukemia.
Related Results
Bi-allelic TET2 alterations are frequently found in NPM1 mutated AML and constitute a distinct subgroup with unfavorable prognosis
Bi-allelic TET2 alterations are frequently found in NPM1 mutated AML and constitute a distinct subgroup with unfavorable prognosis
Abstract
Background: Mutations (mut) in TET2 and NPM1 are common in myeloid neoplasms, with NPM1mut defining a distinct ...
Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?
Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?
Aim: To compare the main features of patients with secondary acute myeloid leukemias (AMLs) after post-myelodysplastic syndrome (AML-post-MDS) or post-myeloproliferative neoplasms ...
Abstract 5120: Surveying the AML surfaceome for novel immunotherapeutic targets
Abstract 5120: Surveying the AML surfaceome for novel immunotherapeutic targets
Abstract
Acute myeloid leukemia (AML) therapy requires very intensive chemotherapy/stem cell transplant that cures only 60% of children and 25% of adults with AML. T...
Chemosensitizing Effect of Fenretinide-Induced NF-κb Inhibition in AML Therapy
Chemosensitizing Effect of Fenretinide-Induced NF-κb Inhibition in AML Therapy
Abstract
INTRODUCTION: Acute myeloid leukemia (AML) represents a genetically heterogeneous hematological malignancy and is among top 10 common cancers in China. Thou...
N-Cadherin Immunoexpression in Patients with Acute Myeloid Leukemia
N-Cadherin Immunoexpression in Patients with Acute Myeloid Leukemia
Abstract
Introduction:
N-cadherin (NCAD) is a member of the cadherin family which is involved in calcium ion dependent adhesion between cells by inter...
Targeting the IRE1α-XBP1s Pathway to Enhance Venetoclax Effectiveness in AML
Targeting the IRE1α-XBP1s Pathway to Enhance Venetoclax Effectiveness in AML
The unfolded protein response (UPR) is a signal transduction network that regulates how cells negotiate ER stress, including chemotherapy, and has been implicated in multiple human...
Role of Stromal Cell-Mediated Notch Signaling in AML Resistance to Chemotherapy
Role of Stromal Cell-Mediated Notch Signaling in AML Resistance to Chemotherapy
Abstract
Introduction: Our group has recently shown that bone marrow-mesenchymal stromal cell (BM-MSCs)-mediated Notch signaling may control survival and chemoresist...
PET-CT Scan for Detection of Extramedullary Acute Myeloid Leukemia
PET-CT Scan for Detection of Extramedullary Acute Myeloid Leukemia
Abstract
Abstract 2156
Background:
Acute myeloid leukemia (AML) at initial diagnosis or relapse may present with ...

